← All workflows

Mta Biological

Draft Biological MTAs in Minutes, Not Hours

12 minutes with CaseMark

Fast lane

We have it from here.

Choose the fast one-off run here, or jump into the workspace when you want saved history, revisions, and a fuller matter workflow.

Run this once here

Best for a quick one-off job. Add your email, upload the files, and we'll run the workflow and send the result to your inbox.

1. Add your email so we know where to send the result.

2. Upload the files you want analyzed.

3. Run the workflow and we'll take it from there.

Use in Workspace

Best for ongoing matters

Save and reopen matters, keep documents together, refine the output, rerun with changes, and export or share polished work product when you're done.

Open in Workspace

Need more context?

Scroll for the workflow details below if you want to review what this run handles, what documents help, and what the output looks like.

If this is part of a live matter, the workspace is the better fit: you can keep your documents together, revisit the result, and keep working without starting from scratch.

Jump to detailsOpen in Workspace

Start here

Run this workflow now

Best for a fast one-off run. Add your email, upload the files, and we'll deliver the result without sending you into the full app.

Workflow

Mta Biological

Step 1 · Deliver to

Step 3 · Run this workflow

Workflow

Mta Biological

Overview

CaseMark's Biological MTA drafting skill generates comprehensive Material Transfer Agreements tailored to the specific biological materials, institutional relationships, and regulatory landscape involved in each transfer. From standard academic exchanges of cell lines to complex commercial transfers of select agents or GMOs, the AI produces agreements that balance scientific collaboration with rigorous IP protection and regulatory compliance.

Drafting Material Transfer Agreements for biological materials is a painstaking process that requires navigating overlapping regulatory frameworks—NIH Guidelines, Bayh-Dole, export controls, and select agent regulations—while balancing the competing interests of scientific openness and IP protection. Technology transfer offices often spend days on a single MTA, creating bottlenecks that delay critical research collaborations.

CaseMark automates the drafting of biological MTAs by analyzing material characteristics, institutional relationships, funding sources, and regulatory classifications to produce comprehensive, compliance-ready agreements. The AI starts from the UBMTA baseline and intelligently adapts provisions for IP allocation, permitted use, publication rights, and biosafety requirements based on the specific circumstances of each transfer.

How it works

  1. 1. Upload your party details, material specifications, research scope, and any upstream restrictions

  2. 2. AI analyzes regulatory requirements, biosafety classifications, and IP considerations to draft a comprehensive MTA

  3. 3. Review and customize provisions for IP allocation, permitted use, publication rights, and compliance terms

  4. 4. Export the finalized Material Transfer Agreement in your preferred format (DOCX, PDF)

What you get

  • Parties & Authority Provisions

  • Material Characterization & Description

  • Permitted Use & Restrictions

  • Intellectual Property Allocation Framework

  • Publication Rights & Review Periods

  • Regulatory Compliance Provisions

  • Biosafety & Handling Requirements

  • Warranties, Disclaimers & Liability

  • Term, Termination & Material Disposition

What it handles

  • Comprehensive material characterization including BSL levels, select agent status, and GMO details

  • Three-tier IP allocation framework for background, materials, and new inventions

  • Regulatory compliance mapping across NIH Guidelines, Bayh-Dole, ITAR/EAR, and select agent rules

  • Publication rights provisions with configurable review periods

  • Permitted use clauses with commercial restriction and third-party transfer controls

  • UBMTA-baseline drafting with intelligent deviation where parties' needs require it

Required documents

  • Party & Material Information

    Details of the providing and receiving institutions, material scientific nomenclature, strain/cell line identifiers, BSL classification, select agent status, and GMO details

    .pdf, .docx, .xlsx

  • Research Scope & Funding Details

    Project description, principal investigator information, grant numbers, and funding source (federal or private) to determine Bayh-Dole applicability

    .pdf, .docx

Supporting documents

  • Upstream MTAs or IP Agreements

    Prior material transfer agreements or third-party IP encumbrances that may restrict downstream use or transfer of the materials

    .pdf, .docx

  • Export Control Classification

    ITAR/EAR classification documentation or institutional export control assessments for the biological materials

    .pdf, .docx

  • IBC or IACUC Approval Documentation

    Institutional Biosafety Committee or Institutional Animal Care and Use Committee approvals relevant to the material or research

    .pdf, .docx

Why teams use it

Reduce MTA drafting time from days to minutes while maintaining regulatory precision across NIH, Bayh-Dole, ITAR/EAR, and select agent frameworks

Ensure consistent three-tier IP allocation and publication rights provisions across all institutional transfers

Automatically flag biosafety, export control, and select agent compliance requirements based on material characteristics

Adapt agreement structure intelligently for academic-to-academic, academic-to-commercial, and cross-border transfer scenarios

Questions

Does CaseMark follow the NIH UBMTA framework?

Yes. CaseMark uses the NIH Uniform Biological Material Transfer Agreement as the baseline framework for all biological MTAs. The AI deviates from the UBMTA only where the specific circumstances of the parties—such as commercial intent, select agent status, or complex IP arrangements—require tailored provisions.

Can it handle transfers involving select agents or GMOs?

Absolutely. CaseMark identifies select agent status and GMO classifications from your inputs and automatically incorporates the appropriate regulatory compliance provisions, including CDC/APHIS select agent regulations, NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, and IBC approval requirements.

How does the AI handle IP allocation between academic and commercial parties?

CaseMark applies a three-tier IP allocation framework: background IP is retained by the originating party, rights in the transferred materials remain with the provider, and new inventions are allocated to the inventive party. This framework is adjusted based on whether the transfer is academic-to-academic, academic-to-commercial, or involves federal funding subject to Bayh-Dole.

Does it address export control requirements like ITAR and EAR?

Yes. CaseMark evaluates the export control classification of the biological materials and incorporates appropriate ITAR or EAR compliance provisions. The AI flags materials that may require export licenses and includes deemed export considerations for foreign national access at recipient institutions.

Can I use CaseMark for both academic-to-academic and academic-to-commercial transfers?

Yes. CaseMark adapts the MTA structure based on the institutional types involved. Academic-to-academic transfers follow a streamlined UBMTA-aligned approach, while transfers involving commercial entities include enhanced provisions for commercialization rights, derivative works, royalty structures, and more restrictive confidentiality terms.

How does CaseMark handle Bayh-Dole compliance for federally funded research?

When federal funding is identified, CaseMark automatically incorporates non-negotiable Bayh-Dole compliance provisions, including government march-in rights, U.S. manufacturing preferences, and invention disclosure obligations. These provisions are flagged as mandatory and cannot be inadvertently omitted during customization.

Related

30b6 Corporate Rep

Draft & Defend 30(b)(6) Depositions in Minutes

30b6 Deposition

Master 30(b)(6) Depositions in Minutes, Not Hours

Abstract of Judgment

Draft Judgment Abstracts in Minutes, Not Hours